Comparison

rv521

Manufacturer InvivoChem LLC
Category
Type Biochemicals
Specific against other
Amount 250mg
Item no. V3810-250mg
CASRN 1903763-82-5
eClass 6.1 32160405
eClass 9.0 32160490
Available
Description
InvivoChem Cat #:V3810CAS #:1903763-82-5 Purity >=98%

Description: RV521 is an orally bioactive, highly potent small-molecule inhibitor of RSV (respiratory syncytial virus) fusion protein. It is with promising pharmaceutical properties and is currently in clinical development for the treatment of RSV disease in paedriatrics, the elderly and immune-compromised patients. RV521 targets (RSV) fusion which is a surface protein that mediates RSV binding to cellular receptors. RSV infection has been an unmet medical need and RV521 is being developed to treat RSV in patients suffering with severe disease, including neonates, the elderly, the immunocompromised and those with underlying cardiovascular or respiratory disease.

References: https://clinicaltrials.gov

Related CAS#: 1903763-83-6 (HCl)

Molecular Weight (MW)
446.45
Formula
C23H22F4N4O
CAS No.
1903763-82-5 (free base);
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 10 mM
Water: < 1mg/mL
Ethanol: < 1mg/mL
Chemical Name
1'-((5-(aminomethyl)-1-(4, 4, 4-trifluorobutyl)-1H-benzo[d]imidazol-2-yl)methyl)-6'-fluorospiro[cyclopropane-1, 3'-indolin]-2'-one
Synonyms
RV521; RV-521; RV 521

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close